Clinical trial update: International Breast Cancer Study Group

Por Price, Karen N, Goldhirsch, Aron
Publicado em 2005

Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy...

Por Giobbie-Hurder, Anita, Price, Karen N, Gelber, Richard D
Publicado em 2009

Impact of SERM adherence on treatment effect: International Breast Cancer Study Group Trials 13-93 and 14-93

Por Pagani, Olivia, Gelber, Shari, Colleoni, Marco, Price, Karen N., Simoncini, Edda
Publicado em 2013

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal w...

Por Regan, Meredith M, Price, Karen N, Giobbie-Hurder, Anita, Thürlimann, Beat, Gelber, Richard D
Publicado em 2011

Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer

Por Sun, Zhuoxin, Goldhirsch, Aron, Price, Karen N., Colleoni, Marco, Ravaioli, Alberto, Simoncini, Edda, Campbell, Ian, Gelber, Richard D., Towler, Mark
Publicado em 2009

Timing of radiotherapy and chemotherapy after breast-conserving surgery for node-positive breast cancer: long term results from IBCSG Trials VI and VII

Por Karlsson, Per, Cole, Bernard F., Price, Karen N., Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron, Castiglione, Monica, Colleoni, Marco, Gruber, Günther
Publicado no Int J Radiat Oncol Biol Phys (2016)

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

Por Chirgwin, Jacquie, Sun, Zhuoxin, Smith, Ian, Price, Karen N., Thürlimann, Beat, Ejlertsen, Bent, Bonnefoi, Hervé, Regan, Meredith M., Goldhirsch, Aron, Coates, Alan S.
Publicado no Breast Cancer Res Treat (2011)

Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy

Por Karlsson, Per, Cole, Bernard F., Colleoni, Marco, Roncadin, Mario, Chua, Boon, Murray, Elizabeth, Price, Karen N., Castiglione-Gertsch, Monica, Goldhirsch, Aron, Gruber, Günther
Publicado em 2010

Adjuvant!(©) Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breas...

Por Paridaens, Robert J., Gelber, Shari, Cole, Bernard F., Gelber, Richard D., Thürlimann, Beat, Price, Karen N., Holmberg, Stig B., Crivellari, Diana, Coates, Alan S., Goldhirsch, Aron
Publicado em 2010

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer. Results from two International Breast Cancer Study Group randomized trials of chemoendocri...

Por Maiorano, Eugenio, Regan, Meredith M., Viale, Giuseppe, Mastropasqua, Mauro G., Colleoni, Marco, Castiglione-Gertsch, Monica, Price, Karen N., Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S.
Publicado em 2009

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

Por Colleoni, Marco, Sun, Zhuoxin, Price, Karen N., Karlsson, Per, Forbes, John F., Thürlimann, Beat, Gianni, Lorenzo, Castiglione, Monica, Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron
Publicado no J Clin Oncol (2016)

Second non-breast primary cancer following adjuvant therapy for early breast cancer: A report from the International Breast Cancer Study Group

Por Gianni, Lorenzo, Gelber, Shari, Ravaioli, Alberto, Price, Karen N., Panzini, Ilaria, Fantini, Manuela, Castiglione-Gertsch, Monica, Pagani, Olivia, Simoncini, Edda, Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron
Publicado em 2008

Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial...

Por Thürlimann, Beat, Price, Karen N., Gelber, Richard D., Holmberg, Stig B., Crivellari, Diana, Colleoni, Marco, Collins, John, Forbes, John F., Castiglione-Gertsch, Monica, Coates, Alan S., Goldhirsch, Aron
Publicado em 2008

Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century

Por Pagani, Olivia, Price, Karen N., Gelber, Richard D., Castiglione-Gertsch, Monica, Holmberg, Stig B., Lindtner, Jurij, Thürlimann, Beat, Collins, John, Fey, Martin F., Coates, Alan S., Goldhirsch, Aron
Publicado em 2009

Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

Por Metzger-Filho, Otto, Sun, Zhuoxin, Viale, Giuseppe, Price, Karen N., Crivellari, Diana, Snyder, Raymond D., Gelber, Richard D., Castiglione-Gertsch, Monica, Coates, Alan S., Goldhirsch, Aron, Cardoso, Fatima
Publicado em 2013

A Risk Score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer

Por Dellapasqua, Silvia, Bagnardi, Vincenzo, Regan, Meredith M., Rotmensz, Nicole, Mastropasqua, Mauro G., Viale, Giuseppe, Maiorano, Eugenio, Price, Karen N., Gelber, Richard D., Castiglione-Gertsch, Monica, Goldhirsch, Aron, Colleoni, Marco
Publicado em 2012

Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adj...

Por Colleoni, Marco, Cole, Bernard F., Viale, Giuseppe, Regan, Meredith M., Price, Karen N., Maiorano, Eugenio, Mastropasqua, Mauro G., Crivellari, Diana, Gelber, Richard D., Goldhirsch, Aron, Coates, Alan S., Gusterson, Barry A.
Publicado em 2010

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

Por Phillips, Kelly Anne, Ribi, Karin, Sun, Zhuoxin, Stephens, Alisa, Thompson, Alastair, Harvey, Vernon, Thürlimann, Beat, Cardoso, Fatima, Pagani, Olivia, Coates, Alan S., Goldhirsch, Aron, Price, Karen N., Gelber, Richard D., Bernhard, Jürg
Publicado em 2010

Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

Por Phillips, Kelly-Anne, Aldridge, Julie, Ribi, Karin, Sun, Zhuoxin, Thompson, Alastair, Harvey, Vernon, Thürlimann, Beat, Cardoso, Fatima, Pagani, Olivia, Coates, Alan S., Goldhirsch, Aron, Price, Karen N., Gelber, Richard D., Bernhard, Jürg
Publicado em 2010

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials

Por Regan, Meredith M., Pagani, Olivia, Fleming, Gini F., Walley, Barbara A., Price, Karen N., Rabaglio, Manuela, Maibach, Rudolf, Ruepp, Barbara, Coates, Alan S., Goldhirschi, Aron, Colleoni, Marco, Gelber, Richard D., Francisl, Prudence A.
Publicado em 2013